Ketamine pretreatment exacerbated 3,4-methylenedioxymethamphetamine-induced central dopamine toxicity

Jing Jer Ke, Ming Che Ho, Chianfang G. Cherng, Yen Ping N. Tsai, Chia Wen Tsai, Lung Yu

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Currently, joint use of ketamine and 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) represents a specific combination of polydrug abuse. Long-lasting and even aggravated central neuronal toxicity associated with mixing ketamine and MDMA use is of special concern. This study was undertaken to examine the modulating effects of ketamine treatment on later MDMA-induced dopamine and serotonin neurotoxicity. We found that repeated administration of ketamine (50 mg/kg × 7) at 1.5-h intervals did not render observable dopamine or serotonin depletion in catecholaminergic target regions examined. In contrast, three consecutive doses of MDMA (20 mg/kg each) at 2-h intervals produced long-lasting dopamine and serotonin depletions in striatum, nucleus accumbens and prefrontal cortex. More importantly, pretreatment with binge doses of ketamine (50 mg/kg × 7 at 1.5-h intervals) 12 h prior to the MDMA dosing regimen (20 mg/kg × 3 at 2-h intervals) aggravated the MDMA-induced dopaminergic toxicity. Nonetheless, such binge doses of ketamine treatment did not affect MDMA-induced serotonergic toxicity. These results, taken together, indicate that binge use of ketamine specifically enhances the MDMA-induced central dopaminergic neurotoxicity in adult mouse brain.

Original languageEnglish
Pages (from-to)65-70
Number of pages6
JournalChinese Journal of Physiology
Volume51
Issue number2
Publication statusPublished - 2008 Jan 1

Fingerprint

N-Methyl-3,4-methylenedioxyamphetamine
Ketamine
Dopamine
Serotonin
Nucleus Accumbens
Prefrontal Cortex
Joints

All Science Journal Classification (ASJC) codes

  • Physiology
  • Physiology (medical)

Cite this

Ke, Jing Jer ; Ho, Ming Che ; Cherng, Chianfang G. ; Tsai, Yen Ping N. ; Tsai, Chia Wen ; Yu, Lung. / Ketamine pretreatment exacerbated 3,4-methylenedioxymethamphetamine-induced central dopamine toxicity. In: Chinese Journal of Physiology. 2008 ; Vol. 51, No. 2. pp. 65-70.
@article{3b5f537582c4457eae16176c29a47635,
title = "Ketamine pretreatment exacerbated 3,4-methylenedioxymethamphetamine-induced central dopamine toxicity",
abstract = "Currently, joint use of ketamine and 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) represents a specific combination of polydrug abuse. Long-lasting and even aggravated central neuronal toxicity associated with mixing ketamine and MDMA use is of special concern. This study was undertaken to examine the modulating effects of ketamine treatment on later MDMA-induced dopamine and serotonin neurotoxicity. We found that repeated administration of ketamine (50 mg/kg × 7) at 1.5-h intervals did not render observable dopamine or serotonin depletion in catecholaminergic target regions examined. In contrast, three consecutive doses of MDMA (20 mg/kg each) at 2-h intervals produced long-lasting dopamine and serotonin depletions in striatum, nucleus accumbens and prefrontal cortex. More importantly, pretreatment with binge doses of ketamine (50 mg/kg × 7 at 1.5-h intervals) 12 h prior to the MDMA dosing regimen (20 mg/kg × 3 at 2-h intervals) aggravated the MDMA-induced dopaminergic toxicity. Nonetheless, such binge doses of ketamine treatment did not affect MDMA-induced serotonergic toxicity. These results, taken together, indicate that binge use of ketamine specifically enhances the MDMA-induced central dopaminergic neurotoxicity in adult mouse brain.",
author = "Ke, {Jing Jer} and Ho, {Ming Che} and Cherng, {Chianfang G.} and Tsai, {Yen Ping N.} and Tsai, {Chia Wen} and Lung Yu",
year = "2008",
month = "1",
day = "1",
language = "English",
volume = "51",
pages = "65--70",
journal = "Chinese Journal of Physiology",
issn = "0304-4920",
publisher = "Chinese Physiological Society",
number = "2",

}

Ketamine pretreatment exacerbated 3,4-methylenedioxymethamphetamine-induced central dopamine toxicity. / Ke, Jing Jer; Ho, Ming Che; Cherng, Chianfang G.; Tsai, Yen Ping N.; Tsai, Chia Wen; Yu, Lung.

In: Chinese Journal of Physiology, Vol. 51, No. 2, 01.01.2008, p. 65-70.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ketamine pretreatment exacerbated 3,4-methylenedioxymethamphetamine-induced central dopamine toxicity

AU - Ke, Jing Jer

AU - Ho, Ming Che

AU - Cherng, Chianfang G.

AU - Tsai, Yen Ping N.

AU - Tsai, Chia Wen

AU - Yu, Lung

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Currently, joint use of ketamine and 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) represents a specific combination of polydrug abuse. Long-lasting and even aggravated central neuronal toxicity associated with mixing ketamine and MDMA use is of special concern. This study was undertaken to examine the modulating effects of ketamine treatment on later MDMA-induced dopamine and serotonin neurotoxicity. We found that repeated administration of ketamine (50 mg/kg × 7) at 1.5-h intervals did not render observable dopamine or serotonin depletion in catecholaminergic target regions examined. In contrast, three consecutive doses of MDMA (20 mg/kg each) at 2-h intervals produced long-lasting dopamine and serotonin depletions in striatum, nucleus accumbens and prefrontal cortex. More importantly, pretreatment with binge doses of ketamine (50 mg/kg × 7 at 1.5-h intervals) 12 h prior to the MDMA dosing regimen (20 mg/kg × 3 at 2-h intervals) aggravated the MDMA-induced dopaminergic toxicity. Nonetheless, such binge doses of ketamine treatment did not affect MDMA-induced serotonergic toxicity. These results, taken together, indicate that binge use of ketamine specifically enhances the MDMA-induced central dopaminergic neurotoxicity in adult mouse brain.

AB - Currently, joint use of ketamine and 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) represents a specific combination of polydrug abuse. Long-lasting and even aggravated central neuronal toxicity associated with mixing ketamine and MDMA use is of special concern. This study was undertaken to examine the modulating effects of ketamine treatment on later MDMA-induced dopamine and serotonin neurotoxicity. We found that repeated administration of ketamine (50 mg/kg × 7) at 1.5-h intervals did not render observable dopamine or serotonin depletion in catecholaminergic target regions examined. In contrast, three consecutive doses of MDMA (20 mg/kg each) at 2-h intervals produced long-lasting dopamine and serotonin depletions in striatum, nucleus accumbens and prefrontal cortex. More importantly, pretreatment with binge doses of ketamine (50 mg/kg × 7 at 1.5-h intervals) 12 h prior to the MDMA dosing regimen (20 mg/kg × 3 at 2-h intervals) aggravated the MDMA-induced dopaminergic toxicity. Nonetheless, such binge doses of ketamine treatment did not affect MDMA-induced serotonergic toxicity. These results, taken together, indicate that binge use of ketamine specifically enhances the MDMA-induced central dopaminergic neurotoxicity in adult mouse brain.

UR - http://www.scopus.com/inward/record.url?scp=51049113848&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=51049113848&partnerID=8YFLogxK

M3 - Article

VL - 51

SP - 65

EP - 70

JO - Chinese Journal of Physiology

JF - Chinese Journal of Physiology

SN - 0304-4920

IS - 2

ER -